Beijing Chunfeng Pharmaceutical is a rapidly growing modern pharmaceutical company in the Beijing-Tianjin-Hebei industrial cluster that  committed leading strategical development for traditional Chinese medicine.

Its management headquarters are located in Guomao CBD, Beijing, its manufacturing base is near the Yanqi Lake in the Huairou District of Beijing – the venue for the APEC summit and the Belt and Road Forum, and its API and TCM extraction plant is in the Beijing-Cangzhou Bohai New Area Biomedical Industrial Park, Hebei province.

Founded in January 2014, Chunfeng Pharmaceutical has established a complete pharmaceutical industry chain covering new drug R&D, Chinese herb plantation, pharmaceutical manufacturing, pharmaceutical sales and modern pharmaceutical logistics after over three years of development. It has been growing its core business for sustainable development and competitiveness.

The company has set up the Chunfeng Shengshi Pharmaceutical Institute for new drug R&D. When it comes to chemical drugs, the company has focused on innovation patents, with two APIs, one Class 1.1 new drug, four Class 2.2 new drugs and two Class 4 new drugs developed.

On top of GMP-compliant herbal slice and granule workshops, the company has Chinese herb plantation and processing bases in main Chinese herb producing areas, including Anhui, Shaanxi, Henan, Sichuan, Tibet and Xinjiang. Its strategic priority is to develop TCM formula granules, TCM decoction pieces and Chinese patent medicines. It has invested heavily to create over 400 kinds of TCM formula granules frequently used in clinical practice. Apart from Chinese patent medicines, it has brought to market 24 kinds of TCM ultrafine powder, over 40 kinds of small-packaged finely-made decoction pieces and two kinds of small-packaged decoction pieces finely processed from imported herbs.

With an area of 60,000 square meters, the company's API plant in the Beijing-Cangzhou Bohai New Area Biomedical Industrial Park has an annual chemical API production capacity of 300 tonnes and annual Chinese herb processing capacity of 6,000 tonnes, giving it a strong API manufacturing advantage.

Chunfeng Pharmaceutical is a strong marketing-driven company, as strong marketing fuels its rapid development. Driven by the urban hospital, county/town end-market and OTC divisions, the company expands the market with multiple models. Besides good product marketing capabilities, it has an extensive distribution network spanning Chinese provinces and regions, with more than 100 tier 1 distributors and over 3,000 tier 2 distributors. It has covered over 1,500 tertiary hospitals and more than 5,000 secondary hospitals, in addition to an initial 15,000+ township health clinics and community hospitals.